-
Poland president accuses Ukraine of not appreciating war support
-
Stocks advance with focus on central banks, tech
-
Amorim unfazed by 'Free Mainoo' T-shirt ahead of Villa clash
-
PSG penalty hero Safonov ended Intercontinental win with broken hand
-
French court rejects Shein suspension
-
'It's so much fun,' says Vonn as she milks her comeback
-
Moscow intent on pressing on in Ukraine: Putin
-
UN declares famine over in Gaza, says 'situation remains critical'
-
Guardiola 'excited' by Man City future, not pondering exit
-
Czechs name veteran coach Koubek for World Cup play-offs
-
PSG penalty hero Safonov out until next year with broken hand
-
Putin says ball in court of Russia's opponents in Ukraine talks
-
Czech Zabystran upsets Odermatt to claim Val Gardena super-G
-
NGOs fear 'catastrophic impact' of new Israel registration rules
-
US suspends green card lottery after MIT professor, Brown University killings
-
Arsenal in the 'right place' as Arteta marks six years at club
-
Sudan's El-Fasher under the RSF, destroyed and 'full of bodies'
-
From farms to court, climate-hit communities take on big polluters
-
Liverpool have 'moved on' from Salah furore, says upbeat Slot
-
Norway crown princess likely to undergo lung transplant
-
Iraq negotiates new coalition under US pressure
-
France's budget hits snag in setback for embattled PM
-
Putin hails Ukraine gains, threatens more, in annual press conference
-
US suspends green card lottery after Brown, MIT professor shootings
-
Chelsea's Maresca says Man City link '100 percent' speculation
-
Dominant Head moves into Bradman territory with fourth Adelaide ton
-
Arsenal battle to stay top of Christmas charts
-
Mexican low-cost airlines Volaris and Viva agree to merger
-
Border casinos caught in Thailand-Cambodia crossfire
-
Australia's Head slams unbeaten 142 to crush England's Ashes hopes
-
Epstein files due as US confronts long-delayed reckoning
-
'Not our enemy': Rush to rearm sparks backlash in east Germany
-
West Indies 110-0, trail by 465, after Conway's epic 227 for New Zealand
-
Arsonists target Bangladesh newspapers after student leader's death
-
Volatile Oracle shares a proxy for Wall Street's AI jitters
-
Tears at tribute to firefighter killed in Hong Kong blaze
-
Seahawks edge Rams in overtime thriller to seize NFC lead
-
Teenager Flagg leads Mavericks to upset of Pistons
-
Australia's Head fires quickfire 68 as England's Ashes hopes fade
-
Japan hikes interest rates to 30-year-high
-
Brazil's top court strikes down law blocking Indigenous land claims
-
Conway falls for 227 as New Zealand pass 500 in West Indies Test
-
'We are ghosts': Britain's migrant night workers
-
Asian markets rise as US inflation eases, Micron soothes tech fears
-
Giant lanterns light up Christmas in Catholic Philippines
-
TikTok: key things to know
-
Putin, emboldened by Ukraine gains, to hold annual presser
-
Deportation fears spur US migrants to entrust guardianship of their children
-
Upstart gangsters shake Japan's yakuza
-
Trump signs $900 bn defense policy bill into law
Indica Labs Joins the AWS Partner Network
Indica Labs, the global leader in AI-powered digital pathology software and services, announced today that they have joined the Amazon Web Services (AWS) Partner Network (APN). The APN is a global community of AWS Partners that leverage programs, expertise, and resources to build, market, and co-sell customer offerings. With the successful completion of the foundational technical review of HALO®, HALO AI, HALO Link, and HALO AP®, these platforms are now AWS Qualified Software. Customers now have confidence that the cloud architecture utilized by Cloud Services for life sciences and clinical deployments is validated by AWS.
"Indica Labs is honored to join the APN," said Eric Runde, Chief Operating Officer, Indica Labs. "AWS has long been recognized as the leading cloud services provider and it is an honor to meet their rigid standards and bring their technical advantages to customers of Indica Labs."
In addition to confidence in the security, performance, and scalability of HALO deployments, an optimized cloud deployment can lead to significant cost savings for customers. In a recent Cloud Services deployment of HALO®, HALO AI, and HALO Link software at the University of Washington BioRepository and Integrated Neuropathology (BRaIN) laboratory, a Cloud Services managed AWS deployment led to a 40% reduction in AWS cost in four months. Dr. C. Dirk Keene, Professor, University of Washington Department of Laboratory Medicine and Pathology Leader, commented, "Moving our HALO deployments to the cloud with Cloud Services has decreased monthly costs substantially and has allowed us to easily collaborate with other research institutions across the country."
The Cloud Services team is comprised of AWS Certified Solution Architects who have deep subject matter expertise in HALO deployments and are experienced with performing data migrations and facilitating custom integrations. Cloud Services customers maintain full ownership over their AWS account while Cloud Services manages all technical aspects of implementation and ongoing maintenance to deliver a highly performant and scalable HALO environment.
As an APN member, Indica Labs joins a global network of 130,000 Partners from more than 200 countries working with AWS to provide innovative solutions, solve technical challenges, win deals, and deliver value to mutual customers.
For more information, visit https://indicalab.com/cloud-services/ and https://aws.amazon.com/partners/.
HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition, HALO AP® provides built-in compliance with FDA 21 CFR Part 11, HIPAA, and GDPR.
About Indica Labs: Indica Labs is the global leader in AI-powered digital pathology software and services. Our flagship HALO® and HALO AI platform revolutionizes quantitative evaluation of whole slide images. HALO Link provides collaborative image management while HALO AP® and HALO AP Dx deliver enterprise digital pathology for primary diagnosis with regulatory clearances in multiple markets. Through a commitment to open pathology, performance, scalability, and ease-of-use, we help pharma companies, diagnostic labs, hospitals, research organizations, and Indica's own Cloud and Pharma Services make discoveries and diagnoses that transform patient care and scientific discovery.
Media Contact:
Eric Runde
[email protected]
SOURCE: Indica Labs
F.Pedersen--AMWN